|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 172 JPY | -1.15% |
|
-3.89% | -29.96% |
SymBio Pharmaceuticals Limited reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was JPY 7,355.51 million. Net income was JPY 1,555.75 million.
Basic earnings per share from continuing operations was JPY 40. Diluted earnings per share from continuing operations was JPY 39.43.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.96% | 50.62M | |
| +33.25% | 704B | |
| +28.59% | 577B | |
| -3.55% | 348B | |
| +18.16% | 327B | |
| +4.36% | 288B | |
| +14.81% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -3.69% | 147B |
SYMBIO PHARMACEUTICALS LIMITED 
